191 related articles for article (PubMed ID: 37684433)
1. MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort.
Goble S; Akambase J; Prieto J; Balderramo D; Ferrer JD; Mattos AZ; Arrese M; Carrera E; Groothuismink ZMA; Oliveira J; Boonstra A; Debes JD
Dig Dis Sci; 2023 Nov; 68(11):4212-4220. PubMed ID: 37684433
[TBL] [Abstract][Full Text] [Related]
2. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.
Donati B; Dongiovanni P; Romeo S; Meroni M; McCain M; Miele L; Petta S; Maier S; Rosso C; De Luca L; Vanni E; Grimaudo S; Romagnoli R; Colli F; Ferri F; Mancina RM; Iruzubieta P; Craxi A; Fracanzani AL; Grieco A; Corradini SG; Aghemo A; Colombo M; Soardo G; Bugianesi E; Reeves H; Anstee QM; Fargion S; Valenti L
Sci Rep; 2017 Jul; 7(1):4492. PubMed ID: 28674415
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the association between MBOAT7 rs641738, TM6SF2 rs58542926 and nonalcoholic fatty liver disease susceptibility.
Xia Y; Huang CX; Li GY; Chen KH; Han L; Tang L; Luo HQ; Bao MH
Clin Res Hepatol Gastroenterol; 2019 Oct; 43(5):533-541. PubMed ID: 30824369
[TBL] [Abstract][Full Text] [Related]
4. Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children.
Zusi C; Morandi A; Maguolo A; Corradi M; Costantini S; Mosca A; Crudele A; Mantovani A; Alisi A; Miraglia Del Giudice E; Targher G; Maffeis C
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1548-1555. PubMed ID: 33810963
[TBL] [Abstract][Full Text] [Related]
5. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
Mancina RM; Dongiovanni P; Petta S; Pingitore P; Meroni M; Rametta R; Borén J; Montalcini T; Pujia A; Wiklund O; Hindy G; Spagnuolo R; Motta BM; Pipitone RM; Craxì A; Fargion S; Nobili V; Käkelä P; Kärjä V; Männistö V; Pihlajamäki J; Reilly DF; Castro-Perez J; Kozlitina J; Valenti L; Romeo S
Gastroenterology; 2016 May; 150(5):1219-1230.e6. PubMed ID: 26850495
[TBL] [Abstract][Full Text] [Related]
6. Genetic predisposition in metabolic-dysfunction-associated fatty liver disease and cardiovascular outcomes-Systematic review.
Ismaiel A; Dumitrascu DL
Eur J Clin Invest; 2020 Oct; 50(10):e13331. PubMed ID: 32589269
[TBL] [Abstract][Full Text] [Related]
7. TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models.
Longo M; Meroni M; Paolini E; Erconi V; Carli F; Fortunato F; Ronchi D; Piciotti R; Sabatini S; Macchi C; Alisi A; Miele L; Soardo G; Comi GP; Valenti L; Ruscica M; Fracanzani AL; Gastaldelli A; Dongiovanni P
Cell Mol Gastroenterol Hepatol; 2022; 13(3):759-788. PubMed ID: 34823063
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study.
Kang Q; Xu J; Luo H; Tan N; Chen H; Cheng R; Pan J; Han Y; Yang Y; Liu D; Xi H; Yu M; Xu X
Gene; 2022 Apr; 820():146235. PubMed ID: 35143946
[TBL] [Abstract][Full Text] [Related]
9. rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis.
Teo K; Abeysekera KWM; Adams L; Aigner E; Anstee QM; Banales JM; Banerjee R; Basu P; Berg T; Bhatnagar P; Buch S; Canbay A; Caprio S; Chatterjee A; Ida Chen YD; Chowdhury A; Daly AK; Datz C; de Gracia Hahn D; DiStefano JK; Dong J; Duret A; ; Emdin C; Fairey M; Gerhard GS; ; Guo X; Hampe J; Hickman M; Heintz L; Hudert C; Hunter H; Kelly M; Kozlitina J; Krawczyk M; Lammert F; Langenberg C; Lavine J; Li L; Lim HK; Loomba R; Luukkonen PK; Melton PE; Mori TA; Palmer ND; Parisinos CA; Pillai SG; Qayyum F; Reichert MC; Romeo S; Rotter JI; Im YR; Santoro N; Schafmayer C; Speliotes EK; Stender S; Stickel F; Still CD; Strnad P; Taylor KD; Tybjærg-Hansen A; Umano GR; Utukuri M; Valenti L; Wagenknecht LE; Wareham NJ; Watanabe RM; Wattacheril J; Yaghootkar H; Yki-Järvinen H; Young KA; Mann JP
J Hepatol; 2021 Jan; 74(1):20-30. PubMed ID: 32882372
[TBL] [Abstract][Full Text] [Related]
10. Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and Europeans.
Fu S; Karim D; Prieto J; Balderramo D; Ferrer JD; Mattos AZ; Arrese M; Carrera E; Oliveira J; Debes JD; Boonstra A
Ann Hepatol; 2024; 29(2):101181. PubMed ID: 37981236
[TBL] [Abstract][Full Text] [Related]
11. The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.
Thabet K; Chan HLY; Petta S; Mangia A; Berg T; Boonstra A; Brouwer WP; Abate ML; Wong VW; Nazmy M; Fischer J; Liddle C; George J; Eslam M
Hepatology; 2017 Jun; 65(6):1840-1850. PubMed ID: 28109005
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis.
Stickel F; Buch S; Nischalke HD; Weiss KH; Gotthardt D; Fischer J; Rosendahl J; Marot A; Elamly M; Casper M; Lammert F; McQuillin A; Zopf S; Spengler U; Marhenke S; Kirstein MM; Vogel A; Eyer F; von Felden J; Wege H; Buch T; Schafmayer C; Braun F; Deltenre P; Berg T; Morgan MY; Hampe J
Am J Gastroenterol; 2018 Oct; 113(10):1475-1483. PubMed ID: 29535416
[TBL] [Abstract][Full Text] [Related]
13. Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.
Liu YL; Patman GL; Leathart JB; Piguet AC; Burt AD; Dufour JF; Day CP; Daly AK; Reeves HL; Anstee QM
J Hepatol; 2014 Jul; 61(1):75-81. PubMed ID: 24607626
[TBL] [Abstract][Full Text] [Related]
14. MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population.
Xu X; Xu H; Liu X; Zhang S; Cao Z; Qiu L; Du X; Liu Y; Wang G; Zhang L; Zhang Y; Zhang J
Front Endocrinol (Lausanne); 2023; 14():1199429. PubMed ID: 37424875
[TBL] [Abstract][Full Text] [Related]
15. The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.
Di Sessa A; Umano GR; Cirillo G; Del Prete A; Iacomino R; Marzuillo P; Del Giudice EM
J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):69-74. PubMed ID: 29601441
[TBL] [Abstract][Full Text] [Related]
16. Lack of evidence supporting a role of TMC4-rs641738 missense variant-MBOAT7- intergenic downstream variant-in the Susceptibility to Nonalcoholic Fatty Liver Disease.
Sookoian S; Flichman D; Garaycoechea ME; Gazzi C; Martino JS; Castaño GO; Pirola CJ
Sci Rep; 2018 Mar; 8(1):5097. PubMed ID: 29572551
[TBL] [Abstract][Full Text] [Related]
17. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
Krawczyk M; Rau M; Schattenberg JM; Bantel H; Pathil A; Demir M; Kluwe J; Boettler T; Lammert F; Geier A;
J Lipid Res; 2017 Jan; 58(1):247-255. PubMed ID: 27836992
[TBL] [Abstract][Full Text] [Related]
18. Effects of MBOAT7 polymorphism and steatosis on liver function assessed by methacetin breath test.
Di Ciaula A; Bonfrate L; Shanmugam H; Weber SN; Krawczyk M; Portincasa P
Eur J Clin Invest; 2023 Aug; 53(8):e14003. PubMed ID: 37029745
[TBL] [Abstract][Full Text] [Related]
19. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.
Lin YC; Chang PF; Chang MH; Ni YH
Liver Int; 2018 Jul; 38(7):1300-1307. PubMed ID: 29314568
[TBL] [Abstract][Full Text] [Related]
20. MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.
Thabet K; Asimakopoulos A; Shojaei M; Romero-Gomez M; Mangia A; Irving WL; Berg T; Dore GJ; Grønbæk H; Sheridan D; Abate ML; Bugianesi E; Weltman M; Mollison L; Cheng W; Riordan S; Fischer J; Spengler U; Nattermann J; Wahid A; Rojas A; White R; Douglas MW; McLeod D; Powell E; Liddle C; van der Poorten D; George J; Eslam M;
Nat Commun; 2016 Sep; 7():12757. PubMed ID: 27630043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
